A phase 2b/3 trial of SYN-010 in patients with irritable bowel syndrome with constipation

Trial Profile

A phase 2b/3 trial of SYN-010 in patients with irritable bowel syndrome with constipation

Planning
Phase of Trial: Phase II/III

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Lovastatin (Primary)
  • Indications Irritable bowel syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 Jun 2017 According to a Synthetic Biologics media release, following collaborative discussions with the U.S. Food and Drug Administration (FDA), the company has received the approval for this study.
    • 03 Aug 2016 According to a Synthetic Biologics media release, the company plans to initiate this trial in 1Q 2017.
    • 10 Mar 2016 According to a Synthetic Biologics media release, the company expects to initiate this trial in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top